Shigeki Fujitani

Shigeki Fujitani

Auto-generated profile, based on publicly available information

Shigeki Fujitani

Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2020 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
LBLiesbet De Bus
Liesbet De Bus
PDPieter Depuydt
Pieter Depuydt
JSJohan Steen
Johan Steen
SDSofie An Magriet Dhaese
Sofie An Magriet Dhaese
KSKen De Smet
Ken De Smet
JWJan J. De Waele
Jan J. De Waele
Purpose The DIANA study aimed to evaluate how often antimicrobial de-escalation (ADE) of empirical treatment is performed in the intensive care unit (ICU) and to estimate the effect of ADE on clinical cure on day 7 following treatment initiation. Methods Adult ICU patients receiving empirical antimicrobial therapy for bacterial infection were studied in a prospective observational study from October 2016 until May 2018. ADE was defined as (1) discontinuation of an antimicrobial in case of empirical combination therapy or (2) replacement of an antimicrobial with the intention to narrow the antimicrobial spectrum, within the first 3 days of therapy. Inverse probability (IP) weighting was used to account for time-varying confounding when estimating the effect of ADE on clinical cure. Results Overall, 1495 patients from 152 ICUs in 28 countries were studied. Combination therapy was prescribed in 50%, and carbapenems were prescribed in 26% of patients. Empirical therapy underwent ADE, no change and change other than ADE within the first 3 days in 16%, 63% and 22%, respectively. Unadjusted mortality at day 28 was 15.8% in the ADE cohort and 19.4% in patients with no change [p = 0.27; RR 0.83 (95% CI 0.60–1.14)]. The IP-weighted relative risk estimate for clinical cure comparing ADE with no-ADE patients (no change or change other than ADE) was 1.37 (95% CI 1.14–1.64). Conclusion ADE was infrequently applied in critically ill-infected patients. The observational effect estimate on clinical cure suggested no deleterious impact of ADE compared to no-ADE. However, residual confounding is likely.

1 April 2011 in American Journal of Infection Control
Verified
Journal Article
Closed access
SFShigeki Fujitani
Shigeki Fujitani
WGW. Lance George
W. Lance George
MMMargie A. Morgan
Margie A. Morgan
SNStephen Nichols
Stephen Nichols
AMA. Rekha Murthy
A. Rekha Murthy

18 February 2014 in Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
JMJun Makino
Jun Makino
SFShigeki Fujitani
Shigeki Fujitani
BTBridget Twohig
Bridget Twohig
SKSteven Krasnica
Steven Krasnica
JOJohn Oropello
John Oropello
In Japan, the continuation of critical care at the end of life is a common practice due to the threat of legal action against physicians that may choose a palliative care approach. This is beginning to change due to public debate related to a series of controversial incidents concerning end-of-life care over the last decade. In this review we contrast and compare the history and evolution of end-of-life care in Japan vs. the USA and other Asian countries. Efforts by the Japanese Society of Intensive Care Medicine (JSICM) to establish better end-of-life care systems, as well as future directions in palliative care in Japan, are discussed.

1 January 2018 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
JKJun Kataoka
Jun Kataoka
AKAkira Kuriyama
Akira Kuriyama
YNYasuhiro Norisue
Yasuhiro Norisue
SFShigeki Fujitani
Shigeki Fujitani
Proportional modes (proportional assist ventilation, PAV, and neurally adjusted ventilatory assist, NAVA) could improve patient–ventilator interaction and consequently may be efficient as a weaning mode. The purpose of this systematic review is to examine whether proportional modes improved patient–ventilator interaction and whether they had an impact on the weaning success and length of mechanical ventilation, in comparison with PSV. We searched PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from inception through May 13, 2018. We included both parallel-group and crossover randomized studies that examined the efficacy of proportional modes in comparison with PSV in mechanically ventilated adults. The primary outcomes were (1) asynchrony index (AI), (2) weaning failure, and (3) duration of mechanical ventilation. We included 15 studies (four evaluated PAV, ten evaluated NAVA, and one evaluated both modes). Although the use of proportional modes was not associated with a reduction in AI (WMD − 1.43; 95% CI − 3.11 to 0.25; p = 0.096; PAV—one study, and NAVA—seven studies), the use of proportional modes was associated with a reduction in patients with AI > 10% (RR 0.15; 95% CI 0.04–0.58; p = 0.006; PAV—two studies, and NAVA—five studies), compared with PSV. There was a significant heterogeneity among studies for AI, especially with NAVA. Compared with PSV, use of proportional modes was associated with a reduction in weaning failure (RR 0.44; 95% CI 0.26–0.75; p = 0.003; PAV—three studies) and duration of mechanical ventilation (WMD − 1.78 days; 95% CI − 3.24 to − 0.32; p = 0.017; PAV—three studies, and NAVA—two studies). Reduced duration of mechanical ventilation was found with PAV but not with NAVA. The use of proportional modes was associated with a reduction in the incidence with AI > 10%, weaning failure and duration of mechanical ventilation, compared with PSV. However, reduced weaning failure and duration of mechanical ventilation were found with only PAV. Due to a significant heterogeneity among studies and an insufficient number of studies, further investigation seems warranted to better understand the impact of proportional modes. Clinical trial registration PROSPERO registration number, CRD42017059791. Registered 20 March 2017

1 March 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
MYMinoru Yoshida
Minoru Yoshida
JIJunichi Izawa
Junichi Izawa
HWHaruaki Wakatake
Haruaki Wakatake
HSHiroki Saito
Hiroki Saito
CKChizu Kawabata
Chizu Kawabata
SFShigeki Fujitani
Shigeki Fujitani

1 January 2020 in Acute Medicine & Surgery
Verified
Journal Article
Open access
Takeshi UnokiTakeshi Unoki
Takeshi Unoki
MTMitsuhiro Tamoto
Mitsuhiro Tamoto
AOAkira Ouchi
Akira Ouchi
HSHideaki Sakuramoto
Hideaki Sakuramoto
ANAsami Nakayama
Asami Nakayama
ATAlexis Tabah
Alexis Tabah
Aim: We investigated personal protective equipment (PPE) use and supply shortage, training, and adverse events among health‐care workers (HCWs) in the intensive care unit (ICU) during the coronavirus disease (COVID‐19) pandemic in Japan and compared the results with an international survey that used the same methodology.Methods: This Web‐based survey was carried out from 14 April to 6 May, 2020, in Japan and included HCWs directly involved in ICU management of COVID‐19 patients. A survey invitation was emailed using the Japanese Society of Intensive Care Medicine’s mailing list.Results: We analyzed 460 valid responses from among 976 responses. The N95/FFP2 mask (77%) was the most frequently used, although half of our respondents reported reuse of single‐use N95/FFP2 masks. The median duration (1 h) of uninterrupted PPE use per shift was less than that in the international study. The most common PPE‐related adverse event was experiencing intense heat (75%). Logistic regression analysis revealed that being a nurse was independently associated with experiencing intense heat.Conclusion: Shortage of PPE and frequent mask reuse were prevalent during the COVID‐19 pandemic in Japan. Intense heat is the most significant symptom, especially for nurses, even with short‐duration PPE use. Strategies to protect HCWs from dehydration and intense heatstroke are needed.